Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 1,166.40
+65.45 (5.94%)
May 4, 2026, 3:29 PM IST
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 594.36 billion as of May 4, 2026. Its market cap has increased by 95.34% in one year.
Market Cap
594.36B
Enterprise Value
619.72B
Revenue
68.68B
Ranking
n/a
PE Ratio
66.93
Stock Price
1,166.40
Market Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 594.36B, an increase of 1,152.91%. That is a compound annual growth rate of 30.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 629.69B | 5.27% |
| Dec 31, 2025 | 598.16B | 84.05% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.06T |
| Mankind Pharma | 927.50B |
| Zydus Lifesciences | 897.46B |
| Aurobindo Pharma | 807.02B |
| Glenmark Pharmaceuticals | 679.06B |
| Alkem Laboratories | 645.65B |
| Ipca Laboratories | 388.40B |
| Ajanta Pharma | 352.52B |